Asia-Pacific Vaccines Market – Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Published Report
  • Feb 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 279
  • No of Figures: 59

Asia-Pacific Vaccines Market, By Composition (Combination Vaccines, Monovaccines), Type (Subunit, Recombinant, Polysaccharide & Conjugate Vaccines, Live-Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, DNA Vaccines), Kind (Routine Vaccine, Recommended Vaccine, Required Vaccine), Age of Administration (Pediatric Vaccine, Adult Vaccine), Diseases (Pneumococcal Disease, Measles, Mumps & Varicella, DPT, Hepatitis, Influenza, Typhoid, Meningococcal, Rabies, Japanese Encephalitis, Yellow Fever, Others), Route of Administration (Injectable, Oral, Nasal), End User (Community Hospitals, Hospitals, Specialty Centres, Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (Japan, China , Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific) Industry Trends and Forecast to 2028

Asia-Pacific Vaccines MarketMarket Analysis and Insights: Asia-Pacific Vaccines Market

Asia-Pacific vaccines market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.9% in the forecast period of 2021 to 2028 and is expected to reach USD 61,988.47 million by 2028. Increasing government support and rise in expenditure in healthcare sector are the major drivers which propelled the demand of the market in the forecast period.

Vaccines are the product that has the capability to reduce the risk of getting a disease by working with the body’s own immune system in order to build up the protection against the deadly pathogens. Various kinds of vaccines have discovered for life threatening diseases which are preventing around 2-3 million deaths every year caused due to diseases such as tetanus, diphtheria, pertussis, measles and influenza among others.

New and novel vaccine launch earns the patients beliefs and provides market with a new future that can have a positive effect on the vaccines market growth. Moreover, new vaccine launch is also depicting that market players are constantly engaged in the vaccines market growth. This thus signifies that introduction of innovative products acts as driver for the vaccines market growth. The regulation processes and document formation of the manufacturing companies in different countries can hamper the growth of the vaccines market. The market players operating in vaccines market are adopting several strategic initiatives expected to provide opportunity for their business in various dimensions and leading the vaccines market growth. The fear among patients related to injections and needle sticks acts as challenge for the vaccines market growth.

The vaccines market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Vaccines MarketAsia-Pacific Vaccines Market Scope and Market Size

The vaccines market is segmented on the basis of composition, type, kind, age of administration, diseases, route of administration, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of composition, the vaccines market is segmented into combination vaccines, monovaccines. In 2021, combination vaccines segment is dominating the market because combination vaccines are effective against multiple diseases by administration of a single shot.
  • On the basis of type, the vaccines market is segmented into subunit, recombinant, polysaccharide and conjugate vaccines, live-attenuated vaccines, inactivated vaccines, toxoid vaccines and DNA vaccines. In 2021, subunit, recombinant, polysaccharide and conjugate vaccine segment is dominating the market because these vaccines have been reported to induce strong immune response on almost everyone who needs them including people with weakened immune systems and long-term health problems.
  • On the basis of kind, the vaccines market is segmented into routine vaccine, recommended vaccine and required vaccine. In 2021, routine vaccine segment is dominating the market because these are mostly used for childhood vaccination and government is putting major emphasis on childhood vaccination all over the world.
  • On the basis of age of administration, the vaccines market is segmented into pediatric vaccine and adult vaccine. In 2021, pediatric vaccine segment is dominating the market because children are more prone to infectious disease among other due to developing immune system and hence needs proper vaccination.
  • On the basis of diseases, the vaccines market is segmented into pneumococcal disease, measles, mumps & varicella, DPT, hepatitis, influenza, typhoid, meningococcal, rabies, Japanese encephalitis, yellow fever and others. In 2021, pneumococcal disease segment is dominating the market because of rising prevalence on pneumonia infection and increasing immunization campaign launch for the betterment of the population.
  • On the basis of route of administration, the vaccines market is segmented into injectable, oral and nasal. In 2021, injectable segment is dominating the market because most of the vaccines are administered via parenteral route and induces strong systemic response when injected via same route.
  • On the basis of end user, the vaccines market is segmented into community hospitals, hospitals, specialty centres, clinics and others. In 2021, community hospitals segment is dominating the market because most of the vaccination and immunization is carried out by regulatory bodies and concerned authorities.
  • On the basis of distribution channel, the vaccines market is segmented into hospital pharmacy, retail pharmacy and online pharmacy. In 2021, hospital pharmacy segment is dominating the market because vaccines are directly procured from the company distributors.

Asia-Pacific Vaccines Market Country Level Analysis

Vaccines market is analyzed and market size information is provided on the basis of composition, type, kind, age of administration, diseases, route of administration, end user and distribution channel as referenced above.

The countries covered in the Asia-Pacific vaccines market report are the Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam and Rest of Asia-Pacific.

Pediatric vaccine segment in the Asia-Pacific region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of rising government awareness program for the child vaccination. Japan is leading the growth of the Asia-Pacific market and pediatric vaccine segment is dominating in this region due to rise in increasing research & development and rising investment for the advanced vaccination.

The country section of the Asia-Pacific vaccines market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Strategic Initiatives by the Market Players and Improvement in Treatment are boosting the Market Growth of Vaccines

The vaccines market also provides you with detailed market analysis for every country growth in vaccines industry with vaccines drugs sales, impact of advancement in the vaccines technology and changes in regulatory scenarios with their support for the vaccines market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Asia-Pacific Vaccines Market Share Analysis

The vaccines market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to vaccines market.

The major companies which are dealing in the Asia-Pacific vaccines market are Bharat Biotech, Biological E Limited, Bio Farma, Merck Sharp & Dohme Corp., (A Subsidiary of Merck & Co., Inc.), Takeda Pharmaceutical Company Limited, Seqirus (A Subsidiary of CSL Limited), Abbott, AstraZeneca, Sanofi, Pfizer Inc., GlaxoSmithKline plc., Lanzhou Biological Products Research Institute Co., Ltd., Janssen Global Services, LLC (A Subsidiary of Johnson & Johnson Services, Inc.), F. Hoffmann-La Roche Ltd, DAIICHI SANKYO COMPANY, LIMITED., ALK, Panacea Biotec Ltd and BAXTER VACCINES (A Subsidiary of Baxter) among others.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the vaccines market.

For instance,

  • In June 2020, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. received approval for GARDASIL 9 (HPV 9 –valent recombinant vaccine). The approved vaccine is indicated for prevention of HPV related cervical, vulvar, vaginal, anal, oropharyngeal, neck and head cancers. HPV is targeting a large population size as both men and women are prone to HPV infections. This approval enhanced the company’s product portfolio and allowed it to generate more revenue.

Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company market in the Vaccines market which also provides the benefit for organization to improve their offering for vaccines.

Customization Available: Asia-Pacific Vaccines Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES

TABLE 1 ASIA-PACIFIC VACCINES MARKET, PIPELINE ANALYSIS

TABLE 2 REGULATIONS IMPOSED BY SEVERAL REGULATORY AGENCIES IN DIFFERENT REGIONS

TABLE 3 RECOMMENDED TEMPERATURE AND STORAGE LENGTH AT VARIOUS LEVEL OF THE COLD CHAIN.

TABLE 4 PROCEDURES FOR REPORTING TO UNICEF VACCINE ARRIVALS.

TABLE 5 LOGISITCS PROCESS ACORSS DIFFERENT REGIONS.

TABLE 6 THE U.S. FUNDING FOR GAVI (2015-2019)

TABLE 7 PRICE OF THE VACCINES BETWEEN THE U.S. AND DEVELOPING COUNTRIES

TABLE 8 VACCINES UNDER CLINICAL TRIAL

TABLE 9 THE SIDE EFFECTS RELATED TO THE VACCINES

TABLE 10 INCREASE IN OPERATIONAL COST COMPONENTS DUE TO COVID-19

TABLE 11 TOTAL NUMBER OF CASES FOR MEASLES REPORTED BY THE TEN COUNTRIES

TABLE 12 ASIA-PACIFIC VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 13 ASIA-PACIFIC COMBINATION VACCINES IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 ASIA-PACIFIC MONO VACCINES IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 ASIA-PACIFIC VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 16 ASIA-PACIFIC SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 ASIA-PACIFIC LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 ASIA-PACIFIC LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 19 ASIA-PACIFIC INACTIVATED VACCINES IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 ASIA-PACIFIC INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 21 ASIA-PACIFIC TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 22 ASIA-PACIFIC TOXOID VACCINES IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 ASIA-PACIFIC VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 24 ASIA-PACIFIC ROUTINE VACCINE IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 ASIA-PACIFIC ROUTINE VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 26 ASIA-PACIFIC RECOMMENDED VACCINE IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 ASIA-PACIFIC RECOMMENDED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 28 ASIA-PACIFIC REQUIRED VACCINE IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 ASIA-PACIFIC REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 30 ASIA-PACIFIC VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 31 ASIA-PACIFIC PEDIATRIC VACCINE IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 ASIA-PACIFIC PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 33 ASIA-PACIFIC ADULT VACCINE IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 ASIA-PACIFIC ADULT IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 35 ASIA-PACIFIC PNEUMOCOCCAL DISEASE IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 36 ASIA-PACIFIC MEASLES, MUMPS & RUBELLA IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 37 ASIA-PACIFIC DPT IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 38 ASIA-PACIFIC HEPATITIS IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 39 ASIA-PACIFIC INFLUENZA IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 40 ASIA-PACIFIC TYPHOID IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 41 ASIA-PACIFIC MENINGOCOCCAL IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 42 ASIA-PACIFIC VARICELLA IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 43 ASIA-PACIFIC RABIES IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 44 ASIA-PACIFIC JAPANESE ENCEPHALITIS IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 45 ASIA-PACIFIC YELLOW FEVER IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 46 ASIA-PACIFIC OTHER IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 47 ASIA-PACIFIC VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 48 ASIA-PACIFIC INJECTABLE IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 49 ASIA-PACIFIC INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 50 ASIA-PACIFIC ORAL IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 51 ASIA-PACIFIC NASAL IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 52 ASIA-PACIFIC VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 53 ASIA-PACIFIC COMMUNITY HOSPITALS IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 54 ASIA-PACIFIC HOSPITALS IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 55 ASIA-PACIFIC SPECIALTY CENTRES IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 56 ASIA-PACIFIC CLINICS IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 57 ASIA-PACIFIC OTHERS IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 58 ASIA-PACIFIC VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 59 ASIA-PACIFIC HOSPITAL PHARMACY IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 60 ASIA-PACIFIC RETAIL PHARMACY IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 61 ASIA-PACIFIC ONLINE PHARMACY IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 62 ASIA-PACIFIC VACCINES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 63 ASIA-PACIFIC VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 64 ASIA-PACIFIC VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 65 ASIA-PACIFIC SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 66 ASIA-PACIFIC LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 67 ASIA-PACIFIC INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 68 ASIA-PACIFIC TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 69 ASIA-PACIFIC VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 70 ASIA-PACIFIC ROUTINE VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 71 ASIA-PACIFIC RECOMMENDED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 72 ASIA-PACIFIC REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 73 ASIA-PACIFIC VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 74 ASIA-PACIFIC PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 75 ASIA-PACIFIC ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 76 ASIA-PACIFIC VACCINES MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 77 ASIA-PACIFIC VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 78 ASIA-PACIFIC INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 79 ASIA-PACIFIC VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 80 ASIA-PACIFIC VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 81 JAPAN VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 82 JAPAN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 83 JAPAN SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 84 JAPAN LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 85 JAPAN INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 86 JAPAN TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 87 JAPAN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 88 JAPAN ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 89 JAPAN RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 90 JAPAN REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 91 JAPAN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 92 JAPAN PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 93 JAPAN ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 94 JAPAN VACCINES MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 95 JAPAN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 96 JAPAN INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 97 JAPAN VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 98 JAPAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 99 CHINAVACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 100 CHINAVACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 101 CHINASUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 102 CHINALIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 103 CHINAINACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 104 CHINATOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 105 CHINAVACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 106 CHINAROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 107 CHINARECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 108 CHINAREQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 109 CHINAVACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 110 CHINAPEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 111 CHINAADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 112 CHINAVACCINES MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 113 CHINAVACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 114 CHINAINJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 115 CHINAVACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 116 CHINA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 117 AUSTRALIAVACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 118 AUSTRALIAVACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 119 AUSTRALIASUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 120 AUSTRALIALIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 121 AUSTRALIAINACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 122 AUSTRALIATOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 123 AUSTRALIAVACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 124 AUSTRALIAROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 125 AUSTRALIARECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 126 AUSTRALIAREQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 127 AUSTRALIAVACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 128 AUSTRALIAPEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 129 AUSTRALIAADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 130 AUSTRALIAVACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 131 AUSTRALIAVACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 132 AUSTRALIAINJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 133 AUSTRALIAVACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 134 AUSTRALIA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 135 INDIAVACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 136 INDIAVACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 137 INDIASUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 138 INDIALIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 139 INDIAINACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 140 INDIATOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 141 INDIAVACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 142 INDIAROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 143 INDIARECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 144 INDIAREQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 145 INDIAVACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 146 INDIAPEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 147 INDIAADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 148 INDIAVACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 149 INDIAVACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 150 INDIAINJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 151 INDIAVACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 152 INDIA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 153 SOUTH KOREA VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 154 SOUTH KOREA VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 155 SOUTH KOREA SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 156 SOUTH KOREA LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 157 SOUTH KOREA INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 158 SOUTH KOREA TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 159 SOUTH KOREA VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 160 SOUTH KOREA ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 161 SOUTH KOREA RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 162 SOUTH KOREA REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 163 SOUTH KOREA VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 164 SOUTH KOREA PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 165 SOUTH KOREA ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 166 SOUTH KOREA VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 167 SOUTH KOREA VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 168 SOUTH KOREA INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 169 SOUTH KOREA VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 170 SOUTH KOREA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 171 SINGAPORE VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 172 SINGAPORE VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 173 SINGAPORE SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 174 SINGAPORE LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 175 SINGAPORE INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 176 SINGAPORE TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 177 SINGAPORE VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 178 SINGAPORE ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 179 SINGAPORE RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 180 SINGAPORE REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 181 SINGAPORE VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 182 SINGAPORE PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 183 SINGAPORE ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 184 SINGAPORE VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 185 SINGAPORE VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 186 SINGAPORE INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 187 SINGAPORE VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 188 SINGAPORE VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 189 MALAYSIA VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 190 MALAYSIA VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 191 MALAYSIA SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 192 MALAYSIA LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 193 MALAYSIA INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 194 MALAYSIA TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 195 MALAYSIA VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 196 MALAYSIA ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 197 MALAYSIA RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 198 MALAYSIA REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 199 MALAYSIA VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 200 MALAYSIA PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 201 MALAYSIA ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 202 MALAYSIA VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 203 MALAYSIA VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 204 MALAYSIA INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 205 MALAYSIA VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 206 MALAYSIA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 207 THAILAND VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 208 THAILAND VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 209 THAILAND SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 210 THAILAND LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 211 THAILAND INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 212 THAILAND TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 213 THAILAND VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 214 THAILAND ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 215 THAILAND RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 216 THAILAND REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 217 THAILAND VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 218 THAILAND PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 219 THAILAND ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 220 THAILAND VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 221 THAILAND VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 222 THAILAND INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 223 THAILAND VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 224 THAILAND VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 225 INDONESIA VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 226 INDONESIA VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 227 INDONESIA SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 228 INDONESIA LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 229 INDONESIA INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 230 INDONESIA TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 231 INDONESIA VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 232 INDONESIA ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 233 INDONESIA RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 234 INDONESIA REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 235 INDONESIA VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 236 INDONESIA PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 237 INDONESIA ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 238 INDONESIA VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 239 INDONESIA VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 240 INDONESIA INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 241 INDONESIA VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 242 INDONESIA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 243 PHILIPPINES VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 244 PHILIPPINES VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 245 PHILIPPINES SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 246 PHILIPPINES LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 247 PHILIPPINES INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 248 PHILIPPINES TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 249 PHILIPPINES VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 250 PHILIPPINES ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 251 PHILIPPINES RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 252 PHILIPPINES REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 253 PHILIPPINES VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 254 PHILIPPINES PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 255 PHILIPPINES ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 256 PHILIPPINES VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 257 PHILIPPINES VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 258 PHILIPPINES INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 259 PHILIPPINES VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 260 PHILIPPINES VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 261 VIETNAM VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 262 VIETNAM VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 263 VIETNAM SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 264 VIETNAM LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 265 VIETNAM INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 266 VIETNAM TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 267 VIETNAM VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 268 VIETNAM ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 269 VIETNAM RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 270 VIETNAM REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 271 VIETNAM VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 272 VIETNAM PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 273 VIETNAM ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 274 VIETNAM VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 275 VIETNAM VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 276 VIETNAM INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 277 VIETNAM VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 278 VIETNAM VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 279 REST OF ASIA-PACIFIC VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Browse Related Reports

Global Companion Animal Vaccines Market - Industry Trends and Forecast to 2026

Global Veterinary/Animal Vaccines Market - Industry Trends and Forecast to 2026

Global Deoxyribonucleic Acid (DNA) Vaccines Market – Industry Trends and Forecast to 2028

Global Personalized Cancer Vaccines Market - Industry Trends and Forecast to 2028

Global Conjugate Vaccines Market – Industry Trends and Forecast to 2027

Global Toxoid Vaccines Market – Industry Trends and Forecast to 2027

Global Live Attenuated Vaccines Market - Industry Trends and Forecast to 2026

Global Porcine Vaccines Market - Industry Trends and Forecast to 2027

Global Inactivated Vaccines Market – Industry Trends and Forecast to 2027

Global Vaccines Market – Industry Trends and Forecast to 2028

Global Malaria Vaccines Market - Industry Trends and Forecast to 2027

Global Bacterial Vaccines Market - Industry Trends and Forecast to 2027

Global Preventable Vaccines Market - Industry Trends and Forecast to 2027

Global Flu Vaccines Market – Industry Trends and Forecast to 2027

Global Avian Influenza Vaccines Market – Industry Trends and Forecast to 2027

Global Cholera Vaccines Market - Industry Trends and Forecast to 2027

Global Meningococcal Vaccines Market - Industry Trends and Forecast to 2027

Global Human Rabies Vaccines Market - Industry Trends and Forecast to 2027

Global Poultry Vaccines Market - Industry Trends and Forecast to 2028

Global Human Combination Vaccines Market - Trends and Forecast to 2028

Europe Vaccines Market – Industry Trends and Forecast to 2028

North America Vaccines Market – Industry Trends and Forecast to 2028

Middle East and Africa Vaccines Market – Industry Trends and Forecast to 2028

Global Measles, Mumps and Rubella Vaccines Market – Industry Trends and Forecast to 2028

Global Bovine Ephemeral Fever Vaccines Market – Industry Trends and Forecast to 2028